ArticleCNS neuroscience & therapeutics2026
Accelerated Magnetic Seizure Therapy for Non-Suicidal Self-Injury in Adolescents With Bipolar Depression.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdolescents with bipolar depression are typically characterized by a high prevalence of non-suicidal self-injury (NSSI), yet effective therapies remain limited. Accelerated magnetic seizure therapy (aMST) has emerged as a promising neuromodulation technique with potential cognitive advantages. However, evidence regarding its clinical efficacy, cognitive impact, neurostructural and functional alterations in adolescents remains unclear.
methodsAdolescents diagnosed with bipolar depression and comorbid NSSI received once-daily accelerated MST sessions. Clinical symptoms, including depression, anxiety, impulsivity, and emotion regulation, were assessed before and after aMST. Cognitive function was evaluated using the MATRICS Consensus Cognitive Battery (MCCB) and autobiographical memory test (AMT). Structural MRI and diffusion tensor imaging (DTI) were collected to compare the potential neurostructural and functional change induced by aMST.
resultsThirty-two adolescents completed the whole aMST protocol. Following aMST, significant reductions were observed in depressive and anxiety symptoms. Improvements were also found in impulsivity and emotion regulation. Assessment of cognitive function revealed no global impairment. Significant enhancements were found in processing speed, working memory, and visual learning, while verbal learning remained largely unchanged. Autobiographical memory (AM) performance was generally preserved, with a reduction in overgeneral autobiographical memory (OGM) for positive cues. Neuroimaging analyses demonstrated no significant changes in total hippocampal volume or hippocampal subfield volumes. DTI analyses suggested increased fractional anisotropy (FA) in the right uncinate fasciculus and increased mean diffusivity (MD) in the left superior longitudinal fasciculus following aMST.
conclusionsThese findings provide preliminary evidence that aMST is associated with clinical improvement and favorable cognitive function in adolescents with comorbid bipolar depression and NSSI. The stably maintained volumes of hippocampal subfield, alongside selective white matter microstructural alterations, suggest that aMST may exert targeted neuroplastic effects while preserving structures which are critical for cognition.
trial registrationChinese Clinical Trial Registry: ChiCTR2500114164.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.